Related Concepts
Related Feeds
Alzheimer's Disease: Early Markers
Alzheimer's disease (AD) is a neurodegenerative disease characterized by progressive cognitive and behavioral decline. Targeting markers in the earliest stages of the disease may mitigate the progression of AD. This feed focuses on early diagnosis and markers, as well as environmental, pharmacological, and drug-response biomarkers associated with this disease.
Alzheimer's Disease: Neuroimaging
Neuroimaging can help identify pathological hallmarks of Alzheimer's disease (AD). Here is the latest research on neuroimaging modalities, including magnetic resonance imaging and positron emission tomography, in AD.
Related Papers
Ophthalmic & Physiological Optics : the Journal of the British College of Ophthalmic Opticians (Optometrists)
R A Armstrong, A B Syed
Psychiatry Research
P SachdevW Haindl
Molecular Imaging and Biology : MIB : the Official Publication of the Academy of Molecular Imaging
Laura L Boles PontoSusan K Schultz
The Journal of Neuropsychiatry and Clinical Neurosciences
Xiying ChenSusan K Schultz
Psychiatry Research
T DierksK Maurer